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UIXm much fundamental knowledge is available concerning the mechanism
of normal and neoplastic growth, efforts to discover a chemical or biological
agentwith selectiveinhibitiveorlethalactionupontumourcells must beempirical
in approach, and involve tests with large numbers of compounds on a variety of
animal tumours. Moreover, because many variables are involved, the activitv
should be observed under various conditions on adequate numbers of test and
control animals, so that the evaluation ofchemo-therapeutic potency is a tedious
procedure. Efforts have been made to overcome some of these difficulties bv
carrying out screening tests ' involving single or successive injections into a
limited series of mice bearing grafted tumours, followed by histological examina-
tion of the tumour and organs, by tests utilizing tumour fiagments trans-
planted to the chorio-allantoic membrane of the chick-embryo or by tissue
culture techniques.
This paper describes tests on several types of grafted tumours in mice with
48 compounds belonging to 6 general chemical groups. Results were almost
entirely negative, and thus indicate that these classes of compound have little
therapeutic effect on implanted mouse tumours, so that more extensive trials
do not seem justified with this tvpe of compound.
EXPERIMENTAL.
Animal8.
The following type oftumours were used:
Transplants from a spindle-celled sarcoma originally induced with diben-
zanthracene by one of us (D.L.W.) (McDonald and Woodhouse, 1938). The
tumour, which is implanted in the leg muscle tissue of albino mice, gives a
high percentage of successful grafts. The new tumours are easily felt after
about 7 days.
A breast tumour, originally spontaneous in a C3H mouse which has been
transplanted in C3Hx (hybrid) mice through some 60 generations. The grafts
develop in 100 per cent ofthese animals, and are palpable in about 4 to 5 days.
The ' Crocker" mouse sarcoma was also used in a limited number of the
tests.
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palpable tumour has been observed, i.e. when theinoculum has been successfully
grafted. Whenever sufficient material was available the tests were done on at
least two of the above types of tumour. The tumour passages and animal test
were carried out by two ofthe authors (D.H. and D.L.W.).
General tehniqe.
Mice bearing small implanted tumours were injected subcutaneously or intra-
peritoneally with 0-2 to 0.5 ml. of solution or suspension of the chemical on
alternate days and observed for regresson orinhibition ofgrowth. It is ofcourse
necessary to ensure that any effects observed on the tumour development are
not due simply to toxic chemical factors affecting the health ofthe animal. In
our experiments the dose given was usually appreciably less than the amount
which produced perceptible impairment of health.
In a few cases injections were given the day following implantation of the
tumours, with subsequent injections every other day. In all experiments the
injected mice were compared with an equal number of control mice, approxi-
matelv 10 to 12 being used for each test, which was continued for 10 to 14 davs.
The overall results were identical by either technique, and since these did not
indicate any significant inhibition, the size and growth rates have not been
detailed.
In some supplementary tests the compounds were injected intravenously in
doses roughly two-fifths of those recorded below. When practicable, the com-
pounds tested were injected in aqueous solution or, in the case of the acidic
compounds, in the presence of a suitable buffer. When the substance was not
sufficiently water-soluble, colloidal solutions were prepared, usually with the
addition of a stabilizer, such as a small amount of gum or gelatine. Two com-
pounds (cholyl cyanide and cholesteryl chloride, No. 6 and 15) were injected
subcutaneously dissolved in cod liver oil.
Materials.
The syntheses of certain chemicals made specially for these studies are
described in a latersection. Most ofthem (No. 10, 14, 18, 22to 29) wereprepared
by workers in the Department of Chemistry, University of Birmingham. The
compounds (36 to 38) in Group D and all those in Group E were obtained from
the Research Department of May & Baker, Ltd. (Dagenham, Essex), and made
available through the co-operation of Dr. A. J. Ewins. Those in Group F were
prepared in the Birmingham Medical School Cancer Research Laboratories.
Group A.
Compounds related to the sterols and bie acids.
This series (Table I) was selected from substances prepared during researches
on cholic acid and its derivatives,which are ofparticular interest in view oftheir
bacteriostatic properties (Stacey and Webb, 1947; Jones, Smith and Webb,
1948). The in vitro antibacterial action of the bile acids, particularly against
certain Gram-positive micro-organisms, is well known (Sobotka, 1937). It has
also been observed that certain bile salts are able to remove the ribonucleic acid
component and other vital constituents from the surface of certain types of
bacteria (Henry and Stacey, 1943). Components structurally related to the bileEXPERIMEINTS ON THE CHEMOTHERAPY OF CANCER
acids were therefore submitted to in vivo tests on tumours to determine whether
they would produce any effect on the growth ofmammalian neoplastic cells.
For this study an endeavour was made to produce substances in which the
original structure was altered in various ways, by the addition of new polar
groups (acid or basic), or by substitution with non-polar radicals in various
positions.
The compounds and dosage per injection are given in Table I. As indicated
previously, in no case was any significant inhibition oftumour growth observed.
TABLE I.
compound& Dosage
(mg.).
1. 23-amino-3. 7. 12-trihydroxynorcholane . . 2-0
2. 23-Guanido , , . . . 1-0
3. 24-Guanido-3.7. 12-trihydroxycholane . . 2-0
4. 24-Amino ,, ,, . . . 1-5
5. Cholyl amidine hydrochloride . . . . 1-4
6. Cholyl cyanide . . . . . . 0.8
7. Cholyl amide . . . . . . . 2-5
8. Triformvl cholyl amide . . . . . 2-0
9. Triformyl cholic acid . . . . . 0-5
10. Triformyl cholyl diazoketone . . . . 0-6
11. Diformyl deoxycholic acid . . . . 1-3
12. Diacetyldeoxycholic acid. . . . 0-7
13. 3.7-Diformyl-12-ketocholanic acid . . . 0-8
14. Dimesyl methyl deoxycholate . . . . 0-5
15. Cholesteryl chloride . . . . . 1-5
16. Cholyl hydrazine . . . . . . 1*0
17. Cholyl ethyl urethane . . . . . 0-1
18. 23-N-methyl amino-3. 7. 12-trihydroxynorcholane 1-0
19. 3-amino-7. 12-dihydroxycholanic acid . 0-3
20. Isoamyl-3-amino-7. 12-dihydroxycholanate 0 O-5
21. Methyl-2-amino-7. 12-dihydroxycholanate . . 0-5
The syntheses of the majority of the compounds listed in Table I have been
recorded elsewhere, and require little further comment. The methods for the
preparation for compounds 1 to 8 have been described by James, Smith, Stacev
and Webb (1946), and for compounds 19 to 21 by Jones, Webb and Smith (1949).
An improved method for the preparation of the formyl derivatives 8. 9, 11 and
13 has also been recorded (Hughes, Smith and Webb, 1949). References to the
preparation of compounds 12, 15, 16 and 17 are summarized by Sobotka (1937).
Group B.
Amino compounds.
A considerable amount of research has been carried out on the chemothera-
peutic properties ofaromatic amino derivatives ofseveral types. Boyland (1946)
found that a number of diamino-diphenvl compounds inhibited growth of spon-
taneous tumours in mice. while other amino compounds which have given some
measure of success with mouse and rat tumours include the N-substituted amino
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stilbenes, and the related stilbamidines (Haddow, Harris, Kon and Roe, 1948).
None of the compounds we tested (Table II) had any measurable effect on the
rate of growth ofthe planted tumours.
TABLE II.
CompoundL ~~~~~~~Dosag (mg.).
22. 1.2-naphthadiamine . . . . . 0-2
23. Glucose-,-naphthanilide . . . . . 0-5
24. Glucose-m-naphthanilide . . . . . 0-2
25. N-acetyl-9-amino-anthracene . . . . 0-4
26. Diaminophenanthrene .. . . . . 0-1
27. Diaminophenenthraquinone . . . . 1-2
28. 6-aminochrysene . . . . . . 04
29. 6-12-diaminochrysene . . . . . 0-2
Group C.
Halogeno compound.
Some chlorinated hydrocarbons have been found to have strong insecticidal
activity, often believed to be associated with their solubility in lipoids. Also
these and other chlorinated ethanes and ethylenes have been found to affect the
germination of seeds, and in particular to cause the liberation of glutathione
(Guthrie, 1939).
In view of the special attributes of fluorine in organic compounds, it was
considered that a short series of halogeno, saturated and unsaturated hydro-
carbons, including some contaiing fluorine, should be tested for their capacity
to inhibit tumour growth (Table HI).
TABLE HII.
Compound- ~~~~~Dosage (mg.).
30. Phenyl pentachloride . . . . . 5-0
31. 2.2'-Diphenyl-1. 1. i-trichloroethane. . . 0-1
32. 2.2'-Di(p-fluorophenyl)-1. 1. 1-trichloroethane . 1-0
33. 4.4'-Difluorobenzophenone . . . . 0-8
34. Tolan tetrachloride . . . . . 0-2
Group D.
Compounds with redox charaderiisc.
Strauss, Cheronis and Strauss (1948) reported that with malignant tissues
reduced tetrazolium salts to the red " formazan " form much imore rapidly than
normal tissues. The group of compounds listed below (Table IV) are of this
type, and it was anticipated that they might have some effect on, for example,
the dehydrogenase systems ofthe tumours. However, no inhibition whatsoever
was observed with the doses given. Moreover, we were unable to confirm the
original observation of Strauss, Cheronis and Strauss (1948) by tests on tumour
or normal tissue slices, and Seligman, Gofstein and Rutenburg (1949) have since
reported that there is no evidence of localization of such compounds in animal
tumours when Pa-tagged compounds are used.EXPERIMEINTS ON THE CHEMOTHEPRAPY OF CANCER
TABLE IV.
Compound. (mg.).
35. 2.3.5-Triphenyltetrazolium chloride. . . 01
36. 3.5-diphenyl-2p-NHI-phenyl-tetrazolium chloride 0.1
37. 2.3.diphenyl-5p-NHI2- ,, ,, ,, 1
38. 2.5.diphenyl-3p-Nc- ,, ,, ,, 01
39. Resazurin . . . . . . . 3-0
35 and 39 were ordinary reagent quality chemicals.
Group E.
Intermnediats in the 8yntkesis ofpenicilic acid.
The series ofderivatives in Table V are intermediates obtained during studies
on the synthesis ofpenicillic acid which all possess the basic skeleton
CH3
\5 4 3 2
C=CC--C-
6 CH3 0 C 1
They were tested because of the biological (bactericidal) activity of penicillic
acid and related compounds.
TABLE V.
Compounds. Dosag (mg.).
40. 5-Methyl4-hydroxyhex-5-en-2-inoic acid . . . . . 0-8
41. 5-Methyl4-hydroxy-3-methoxyhexa-2:5 dienoic acid lactone. . 1*0
42. 5-Methyl4-hydroxy-3-methoxyhexa-2:4 dienoic acid lactone. . 0-4
43. 6-Bromo-5-Methyl-4-hydroxy-3-methoxyhexa-2:4-dienoic acid
lactone . . . . . . . . . . 04
44. 5-Methyl-5-hydroxy-3-methoxy4-ketohex-2 enoic acid. . . 5-0
Group F.
Zinc derivative8.
Evidence has been found of significant differences between the zinc content
of normal and some malignant tissues, the latter often having a much higher
content (Heath, 1949).
Furthermore, various amino acids (Beard, 1942) and malonic acid have been
found to have inhibitory effects on tumour growth (Boyland, 1940; Woodhouse,
1947). The inhibition in the form of such co-ordinated metallic compounds
was thought to offer some advantage. The compounds showed moderate toxic
properties; the doses shown in Table VI are close to the maximum tolerated by
animals of 25 to 30 g. weight given repeated injections.
TABLE VI.
i'0 Dosag Compounds. Zinc. (mg.).
45. Zinc-glycine . . 15 5 . 10
46. Zinc-tyrosine . . 10 1 . 1-3
47. Zinc-glutamic acid. . 20 4 . 09
48. Zinc-Malonic acid . . 31'5 .10
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The compounds were prepared by warming the amino acid in the presence of
excess fieshly precipitated zinc hydroxide. After filtering off excess zinc
hydroxide the compounds were isolated by careful evaporation and crystallization.
The zinc content was determined onthe dried preparations byLang'sferricyanide-
iodide method.
Special Syntheses.
Triformyl cholyl diazoketone (10), isolated as an intermediarv in the synthesis
ofhomocholic acid, was prepared from triformyl cholvl chloride and diazomethane
according to the method of Ruzicka, Plattner and Heusser (1944). Repeated
recrystallization from Grignard-dried methanol gave triformyl cholyl diazoketone
as white needles (m.p. 135 to 1360. [x] 0 + 86-2, in chloroform (c= 11). (Found:
C, 64-9; H, 7 6.; Calc. for C.8H4007N2; C, 65 1; H. 77- per cent.)
Dimesyl methyl deoxycholate (14).-M1ethyl deoxycholate (2 g.) was thoroughly
dried by distillation with sodium-dry ethanol and benzene, and the resulting
syrup dissolved in drv pyridine (4 c.c.). The solution was cooled in ice, and
freshlv distilled methane sulphonyl chloride (1 c.c.) added in 5 equal proportions
of 0-2 c.c., over a period of approximatelv 1 hour. After standing at room
temperature for 3 days, a few drops of water were stirred into the dark nearly-
solid mixture, and the whole stirred into excess water. The sticky solid which
separated hardened on trituration, and was filtered off. The aqueous filtrate
was extracted with chloroform (6 times) and the extract washed with water.
ice-cold iN hydrochloric acid (5 times) to remove pyridine, again with water.
sodium bicarbonate solution, and finallv with water. After drving (CaCl2),
evaporation of this extract yielded only a very small amount of a brown syrup.
indicating that only a small fraction ofthe product remained in aqueous solution-
The filtered solid was dissolved in ethanol and a little acetone, and the solution
slowly run into water (800 c.c.) with vigorous stirring. The brownish solid which
separated was filtered off and dried. It could not be crystallized from any ofthe
various solvents used. The product was therefore dried as before by distillation
with dry benzene and ethanol, dissolved in dry pyridine and again treated with
mesyl chloride (1 c.c.). After standing overnight at room temperature the
solution was heated at 50° for 1 hour. and then worked up as before. An initial
purification was effected by dissolving the crude product in acetone and stirring
into brine. The precipitated solid was dissolved in acetone and the solution
decolorized with charcoal. Evaporation of the solution gave a svrup which
crystallized in colourless monoclinic plates from a mixture of dry acetone, dry
benzene and dry light petroleum. The crystals (1-05 g.. 38 per cent) had m.p.
63-. depressed to 5V in admixtures with methyl deoxycholate (m.p. 63 50). and
showed [x] 12- 50 in chloroform (c. 1.0). (Found: S, 11-8. Calc. for
C2.,7H4608S2: S. 11-4 per cent.)
23-N-methylamino-3:7:12-trihydroxynorcholane (18). An attempt was made to
increase the basicitv of 23-amino-3:7:12-trihvdroxvnorcholane by the formation
of its N-methyl derivative following the method of Eckhardt (1938) for the pre-
paration ofN-meth-l-7-amino-cholestane. The first step in the reaction involved
the preparation of the free base from the hydrochloride. Neutralization of an
ethanolic solution of the latter with sodium hvdroxide in ethanol proved unsuit-
able, since water liberated during the reaction. as well as traces of carbonate inEXPERIMENTS ON THE CHEMOTHERAPY OF CANCER
the alkali, tended to react with the free base. The following method ofsynthesis
proved suitable:
A solution of 23-amino-3:7:12-trihvdroxvnorcholane-hvdrochloride (2 g.) in
ethanol (10 ml.) containing sodium ethoxide (from 01I g. Na) was kept at 60°
for 2 hours. The cooled solution was filtered to remove the precipitate ofsodium
chloride, and evaporated to dryness under diminished pressure at 500 (bath
temperature) in an atmosphere of nitrogen. The dry residue was extracted
(3 times) under reflux with dry ether (10 ml.). The combined ethereal extracts
(in nitrogen) were cooled in ice and methyl iodide (3-5 ml.) added. The white
crvstalline product which separated on standing overnight at 0° was collected
and dried in vacuo at room temperature. Recrystallization from acetone con-
taining hydriodic acid (0-02N) gave N-methvl-23-amino-3:7:12-trihydroxynor-
cholane hvdroiodide (0 8 g., m.p. 268 to 2690). Found: C, 54 9; H. 2; N, 2 4.
C24H4403NI requires C, 55 1; H, 8 4 ; N, 2 6 per cent.)
1:2 Naphthadiamine (22).-Treatment of 2-naphthvlamine (10 g.) in warm
ethanol (65 ml.) with a solution of benzene diazonium chloride from aniline (7 g.)
according to, the method of Bamberger and Schieffelin (1889) gave I-Benz-azo-
2-naphthylamine (10 2 g., m.p. 102-104'. after recrystallization from ethvl
acetate). The latter compound (5 g.) was reduced with zinc dust and acetic acid
in the usual way. and the resulting solution poured into 0-2 N sulphuric acid
(100ml.). The precipitated sulphate was dissolved in warm 5N'sodium hydroxide
(40 ml.) and the solution filtered. On cooling, light brown crystals separated.
which were filtered, washed with water and dried. Recrystallization from
aqueous ethanol yielded needles of 1:2-diaminonaphthalene (l12 g., m.p. 970).
Glucose-j-naphthadiamrine (23).-A solution of 2-naphthylamine (2 g. purified
by sublimation at 1120) in ethanol (30 ml.) was boiled under reflux with glucose
(1 g.) for 1 hour. Excess ethanol was then removed by evaporation. and the
residual solution treated with ether (80 to 100 ml.). The crystals of glucose-h-
naphthanilide (0.8 g., m.p. 115 to 1170) which separated on standing were filtered,
washed with ether and dried in uacuo.
Glucose- -napththanilide (24) was prepared from l-naphthvlamine (purified by
sublimation at 500) and glucose in an identical manner.
N-acetyl-9-aminoanthracene (25). 9-Aminoanthracene was prepared from
anthracene by the formation and subsequent reduction of 9-nitroanthracene
according to the method ofDinroth (1901). The N-acetvl derivative was formed
when a solution of 9-aminoanthracene (1-2 g.) in redistilled acetic anhvdride
(7d ml.) was allowed to stand in the cold. The crystalline product which separated
was collected. washed first with acetic acid and then with ethanol and dried.
Recrvstallization from aqueous ethanol yielded N-acetvl-9-aminoanthracene
(08 g., m.p. 273 to 2740).
9:10-Diaminophenanthrene (26) was obtained by the reduction of phena-n
thraquinone dioxine in ethanol solution with zinc chloride-hydrochloric acid
according to the method of Schmidt and Soll (1907). The crude product was
rerystallized from ethanol to give 9:10 diamino phenanthrene (1-1 g.I m.p. 154
to 1550) as needles. (Found: -N. 16'4; Calc. for C14H1N2; IN, 16 6 per cent.)
2:7-Diaminophenanthraquinone (27).-A solution of phenanthraquinone (10 g.)
and methylamine hydrochloride (8 8 g.) in dry benzene (35 ml.) was boiled under
reflux for 6 hours (Jaffe and Day. 1943). The residual solid was extracted
repeatedly with boiling benzene (50 ml.). The combined benzene extracts were
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filtered to remove unchanged phenanthraquinone (2-1 g., m.p. 185 to 1950), and
evaporated under reduced pressure at 50° (bath temperature). The residual
yellow solid was extracted with 5N hydrochloric acid, ethanol, and then with
ethylacetate. Evaporation of the ethyl acetate extract to half-volume under
reduced pressure gave a solid which, on crystallization and recrystallization from
ethanol, afforded 2:7-diaminophenanthraquinone (1-2 g., m.p. 209 to 2100).
6-Amino-chry8ene (28) was prepared by the following modification of the
method of Newman and Cathcarte (1940). Reduction of the intermediary,
6-nitro-chrysene was more efficiently carried out with iron filings and hydro-
chloric acid than with red phosphorus and hydriodic acid.
To a solution of chrysene (10 g.) in glacial acetic acid (280 ml.) was added a
mixture ofconcentrated nitric acid (8 ml.) and concentrated sulphuric acid (10 ml.)
in glacial acetic acid (100 ml.). The yellow precipitate which separated from
the reaction mixture was collected after 30 minutes, dried and recrystallized
from aqueous pyridine. The resulting product was dissolved inabsolute benzene,
and the solution passed first through a column of alumina and then through
silicon dioxide. Evaporation of the benzene solution gave 6-nitro chrysene
(7 5 g, m.p. 212 to 2130).
Reduction of 6-nitrochry8ene.
(a) With red phoIphooru andhydriodic acid.-A mixture of 6-nitrochrysene
(2 g.) and red phosphorus (0 5 g.) in hydriodic acid (D 1 7, 4 5 ml.) was heated
under reflux on a sand tray and glacial acetic acid (10 ml.) cautiously added.
After hour the mixture was cooled, and the reddish-brown solid which separated
extracted several times with benzene (60 ml.). The combined benzene extracts
were washed with water, sodium thiosulphate solution and again with water.
After drying(MgSO4), the solution was concentrated under diminished pressure
in an atmosphere of nitrogen at 400 (bath temperature) to yield a white solid
(m.p. 270 to 2760). The latter was rapidlyfiltered and dissolved immediately in
acetic anhydride (8 ml.) and glacial acetic acid (3 ml.). After 30 minutes at room
temperature the solution was poured into water, and the white precipitate which
separatedcollected, washedwithwateranddried. Recrystallization from aqueous
ethanol afforded 6-N-acetyl-aminochrysene (0.37 g., m.p. 297 to299°). (b) Iron fdling and hydrochloric acid.-6-nitrochrysene (4 g.) was added with
vigorous stirring to amixture ofironfilings (2 1g.), 5 N-hydrochloric acid (20 ml.),
andwater (5ml.) at 95to 1000; whenthe 6-nitrochrysene had dissolved completely
the heating was discontinued, and sodium carbonate (6 g.) added. The solution
was then cooled, fitered and evaporated under reduced pressure. The residue
was extracted with ethanol, the combined extracts dried and evaporated under
reduced pressure at 40°. The crystalline product which separated was recrys-
talized from ethanol to give 6-aminochrysene (2 7 g., m.p. 274 to 2750).
6:12-Dia&minohrdrene (29).-Chrysene (6 g.) in glacial acetic acid (210 ml.)
wastreatedat 900with concentratednitric acid (63 ml.) andconcentrated sulphuric
acid (6 ml.) to give 6:12-dinitrochrysene (7.3 g., m.p. 372 to 3760). The latter
(5 g.) was added slowly with vigorous stirring to a mixture of 5N hydrochloric
acid (25 ml.) and iron filings (4.2 g.) at 95°. After 2 hours sodium carbonate
(5 g.) was added, the solution cooled and filtered. The fitrate was extracted
several times with ether (100 ml.), the combined ethereAl extracts washed withEXPERIMENTS ON THE CHEMOTHERAPY OF CANCER 429
water, dried (MgSO4), and evaporated to drvness. The residual white solid, on
recrystallization from ethanol, gave 6:12 diaminochrysene (3.9 g.), which was
converted to its stable diacetyl derivative in the usual way. Recrystallized
from aqueous ethanol, the 6:12-diacetylamino chrvsene formed needles (362 to
3650).
SUMMARY.
Forty-eight chemicals belonging to 6 general groups have been tested for
tumour inhibition by injection into mice bearing grafted sarcomas and carcinomas
with negative results.
The groupings were:
A. Compounds related to the sterols and bile acids.
B. Amino compounds.
c. Halogeno-compounds.
D. Compounds with Redox characteristics.
E. Intermediates in the synthesis ofpenicillic acid.
F. Zinc derivatives of amino acids.
The syntheses ofthe compounds specially prepared for this work are described.
This work was carried out on behalfofthe Birmingham Branch ofthe British
Empire Cancer Campaign.
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